This implies not only the significance of NGF in reducing the extent of EAE lesions [112] but also opens up a new possibility to enhance the NGF beneficial anti-inflammatory potential in MS patients by removing these antibodies by means of TPE [113]. Here, NGF is linked to myeloid sarcoma.